Single center experience of 90Y-Ibritumomab tiuxetan in the older population with non-hodgkin lymphoma.

被引：0
|
作者：
Agrawal, Vaibhav [1 ]
Castillo, Jose Isaac [1 ]
Raup, Kelly [1 ]
Girton, Treanna [1 ]
Collins, Scott R. [1 ]
Brady, James O. [1 ]
Khan, Sharif S. [1 ]
Vadakara, Joseph [1 ]
机构：
[1] Geisinger Med Ctr, Danville, PA 17822 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e19035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19035
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SINGLE CENTER EXPERIENCE OF 90Y-IBRITUMOMAB TIUXETAN IN THE OLDER POPULATION WITH NON-HODGKIN LYMPHOMA
    Agrawal, V.
    Castillo, J.
    Raup, K.
    Girton, T.
    Collins, S.
    Brady, J.
    Vadakara, J.
    Khan, S.
    HAEMATOLOGICA, 2016, 101 : 481 - 482
  • [2] Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma
    Marcus, R
    SEMINARS IN ONCOLOGY, 2005, 32 (01) : S36 - S43
  • [3] Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma
    Younes, A.
    Wong, F.
    ANNALS OF ONCOLOGY, 2009, 20 (06) : 1147 - 1148
  • [4] RIT WITH 90Y-IBRITUMOMAB TIUXETAN IMPROVES THE RESPONSE IN AGGRESSIVE NON-HODGKIN LYMPHOMA
    Montes Limon, A.
    Andrade Campos, M.
    Murillo Flores, I.
    Grasa Ulrich, J. M.
    Lievano, P.
    Baringo, T.
    Giraldo Castellanos, P.
    HAEMATOLOGICA, 2012, 97 : 667 - 668
  • [5] 90Y-ibritumomab tiuxetan therapy of follicular non-Hodgkin's lymphoma: the experience in our hospital
    Ramal Leiva, D.
    Sabate-Llobera, A.
    Mercadal Vilchez, S.
    Garcia Munoz, N.
    Roca Engronyat, M.
    Mora Salvado, J.
    Martin-Comin, J.
    Gonzalez-Barca, E.
    Ricart Brulles, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S429 - S429
  • [6] Efficacy of 90Y-Ibritumomab Tiuxetan in the Older Population with Non-Hodgkin Lymphoma Pre-Treated with Rituximab-Based Regimens: A Single-Institution Experience
    Agrawal, Vaibhav
    Diane, Smelser T.
    Castillo, Jose I.
    Raup, Kelly
    Treanna, Girton D.
    Collins, Scotty R.
    Brady, James O.
    Khan, Sharif S.
    BLOOD, 2017, 130
  • [7] Experience on Therapy with 90Y Ibritumomab Tiuxetan in Relapsed/Refractory Non-Hodgkin Lymphoma. Analysis of Outcomes
    Baringo, T.
    Giraldo, P.
    Lievano, P.
    Navarro, P.
    Arroyo, E.
    Ananos, M.
    de la Cueva, L.
    Abos, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S352 - S352
  • [8] 90Y-ibritumomab tiuxetan:: Rationale for patient selection in the treatment of indolent non-Hodgkin's lymphoma
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2005, 32 (01) : S44 - S49
  • [9] Efficacy of 90Y-ibritumomab tiuxetan (Zevalin) in refractory or relapsed MALT gastric non Hodgkin's lymphoma.
    Vanazzi, Anna
    Ferrucci, Pier F.
    Grana, Chiara
    Pruneri, Giancarlo
    Crosta, Cristiano
    Pinto, Antonello
    Chinol, Marco
    Paganelli, Giovanni
    Martinelli, Giovanni
    BLOOD, 2006, 108 (11) : 784A - 784A
  • [10] RADIOIMMUNOTHERAPY CASES REGISTRY: RECURRENT OR REFRACTORY NON-HODGKIN LYMPHOMA TREATED WITH 90Y-IBRITUMOMAB TIUXETAN
    Gomez-Codina, J.
    Giraldo, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 232 - 232
12345